title: Identification of C-terminal Hsp70-interacting protein as a mediator of tumour necrosis factor action in osteoblast differentiation by targeting osterix for degradation.
abstract: In patients with inflammatory arthritis, tumour necrosis factor (TNF)-α are overproduced in inflamed joints. This leads to local erosion of cartilage and bone, periarticular osteopenia, as well as osteoporosis. But less is known regarding the molecular mechanisms that mediate the effect of TNF-α on osteoblast function. The purpose of this study was to test that C terminus of Hsc70-interacting protein (CHIP) has a specific role in suppressing the osteogenic activity of osteoblasts under inflammatory conditions. C2C12, MC3T3-E1 and HEK293T cell lines were cultured and cotransfected with related plasmids. After transfection, the cells were cultured further in the presence or absence of murine TNF-α and subjected to real time RT-PCR, Western blot, Ubiquitination assay, Co-immunoprecipitation, Luciferase reporter assay, Small interfering RNAs and Mineralization assay. The expression levels of TNF-α-induced CHIP and Osx were examined by RT-PCR and Western blot analysis. Co-immunoprecipitation and ubiquitination assays revealed ubiquitinated Osx, confirmed that CHIP indeed interacted with Osx and identified K55 and K386 residues as the ubiquitination sites in Osx, Luciferase reporter assay and Small interfering RNAs examined whether TNF-α target the bone morphogenetic protein signalling through CHIP. We established stable cell lines with the overexpression of HA-CHIP, Mineralization assay and CHIP siRNA demonstrated the important roles of CHIP on osteoblast function in conditions in which TNF-α is overexpressed. We found that the K55 and K386 residues are ubiquitination site(s) in Osx, and that TNF-α inhibits osteoblast differentiation by promoting Osx degradation through up-regulation of E3 ubiquitin ligase CHIP in osteoblast. Thus, CHIP targets Osx for ubiquitination and degradation in osteoblasts after chronic exposure to TNF-α, and inhibition of CHIP expression in osteoblasts may be a new mechanism to limit inflammation-mediated osteoporosis by promoting their differentiation into osteoblasts.
authors.affiliation: Department of Rheumatology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
authors.forename: Jianmin
authors.initials: J
authors.lastname: Xie
authors.affiliation: Department of Rheumatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
authors.forename: Jieruo
authors.initials: J
authors.lastname: Gu
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D019485:Bone Morphogenetic Proteins / Q000378:metabolism; D002113:Calcification, Physiologic / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects*; D057809:HEK293 Cells; D006801:Humans; D008239:Lysine / Q000378:metabolism; D051379:Mice; D008969:Molecular Sequence Data; D010006:Osteoblasts / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*; D011485:Protein Binding / Q000187:drug effects; D059748:Proteolysis / Q000187:drug effects*; D060888:Real-Time Polymerase Chain Reaction; D015398:Signal Transduction / Q000187:drug effects; D000076182:Sp7 Transcription Factor; D014157:Transcription Factors / Q000737:chemistry / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*; D025801:Ubiquitin / Q000378:metabolism; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism*; D054875:Ubiquitination / Q000187:drug effects
chemical_list: D019485:Bone Morphogenetic Proteins; D000076182:Sp7 Transcription Factor; C479466:Sp7 protein, mouse; D014157:Transcription Factors; D014409:Tumor Necrosis Factor-alpha; D025801:Ubiquitin; C492951:Stub1 protein, mouse; D044767:Ubiquitin-Protein Ligases; D008239:Lysine
keywords: CHIP; TNF-α; osteoblast; osterix
references.citation: J Cell Biochem. 2006 Dec 1;99(5):1233-9
references.pmid: 16795049
references.citation: Bone. 1996 Sep;19(3):263-70
references.pmid: 8873967
references.citation: Nat Rev Mol Cell Biol. 2005 Jan;6(1):79-87
references.pmid: 15688069
references.citation: Nature. 2014 Jun 5;510(7503):162-6
references.pmid: 24784582
references.citation: Nat Cell Biol. 2001 Jan;3(1):100-5
references.pmid: 11146634
references.citation: Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):12919-24
references.pmid: 20615976
references.citation: Nat Rev Mol Cell Biol. 2012 Jan;13(1):27-38
references.pmid: 22189423
references.citation: J Biol Chem. 2003 Oct 3;278(40):39029-36
references.pmid: 12871975
references.citation: Inflammation. 1992 Dec;16(6):587-601
references.pmid: 1459694
references.citation: J Cell Biol. 2008 Jun 16;181(6):959-72
references.pmid: 18541707
references.citation: J Bone Miner Res. 2012 Jul;27(7):1607-18
references.pmid: 22407479
references.citation: Arthritis Rheum. 1998 Feb;41(2):274-83
references.pmid: 9485085
references.citation: J Biol Chem. 2008 Aug 22;283(34):23084-92
references.pmid: 18567580
references.citation: Cytokine. 2003 Apr;22(1-2):33-41
references.pmid: 12946103
references.citation: Cell Res. 2014 Sep;24(9):1025-6
references.pmid: 24946738
references.citation: Biochem Biophys Res Commun. 2003 Sep 26;309(3):689-94
references.pmid: 12963046
references.citation: Cell Signal. 2013 Oct;25(10):2069-78
references.pmid: 23602936
references.citation: J Biomed Sci. 2012;19:67
references.pmid: 22827778
references.citation: J Immunol Methods. 1984 May 25;70(2):257-68
references.pmid: 6609997
references.citation: Immunol Cell Biol. 2013 Jul;91(6):393-401
references.pmid: 23628802
references.citation: Arthritis Rheumatol. 2015 Jan;67(1):39-50
references.pmid: 25303734
references.citation: J Biol Chem. 2013 Oct 25;288(43):31069-79
references.pmid: 23990462
references.citation: Ann Rheum Dis. 2002 Nov;61 Suppl 2:ii84-6
references.pmid: 12379632
references.citation: Gene. 2003 Dec 4;321:1-15
references.pmid: 14636987
references.citation: J Biol Chem. 2002 Jan 25;277(4):2695-701
references.pmid: 11723115
references.citation: J Bone Miner Res. 1998 May;13(5):793-802
references.pmid: 9610743
references.citation: J Biol Chem. 2014 Nov 14;289(46):31879-90
references.pmid: 25231984
references.citation: Cell. 1997 May 30;89(5):747-54
references.pmid: 9182762
references.citation: Nat Genet. 1997 Jul;16(3):307-10
references.pmid: 9207800
references.citation: Mol Cell Biol. 2011 May;31(9):1905-20
references.pmid: 21343341
references.citation: J Bone Miner Res. 2010 Jun;25(6):1246-56
references.pmid: 20200942
references.citation: Rev Endocr Metab Disord. 2006 Jun;7(1-2):1-16
references.pmid: 17051438
references.citation: J Biol Chem. 2011 May 6;286(18):15883-94
references.pmid: 21454478
references.citation: J Biol Chem. 2008 Oct 24;283(43):29119-25
references.pmid: 18703512
references.citation: Nat Rev Rheumatol. 2010 Feb;6(2):75-81
references.pmid: 20125174
references.citation: J Biol Chem. 2006 Mar 10;281(10):6297-306
references.pmid: 16410254
references.citation: Annu Rev Biochem. 2013;82:387-414
references.pmid: 23495935
references.citation: J Immunol. 1992 Feb 1;148(3):788-94
references.pmid: 1309841
references.citation: Nat Med. 2007 Feb;13(2):156-63
references.pmid: 17237793
references.citation: Arch Biochem Biophys. 2008 May 15;473(2):98-105
references.pmid: 18331818
references.citation: Mol Cell Endocrinol. 2012 Jan 2;348(1):224-32
references.pmid: 21888945
references.citation: Endocrinology. 1987 Nov;121(5):1596-604
references.pmid: 3665833
references.citation: Biochem Biophys Res Commun. 2000 Oct 5;276(3):813-6
references.pmid: 11027552
references.citation: J Bone Miner Res. 2009 Jun;24(6):1055-65
references.pmid: 19113927
references.citation: Clin Exp Rheumatol. 2013 Jul-Aug;31(4 Suppl 78):S33-6
references.pmid: 24129134
references.citation: J Cell Physiol. 2013 May;228(5):1076-86
references.pmid: 23042144
references.citation: Cell. 2002 Jan 11;108(1):17-29
references.pmid: 11792318
references.citation: Clin Calcium. 2007 Oct;17(10):1607-12
references.pmid: 17906416